HCC lacking both O6-methylguanine-DNA methyltransferase (MGMT) and hMLH1 is correlated with an advanced stage and a poor prognosis. Mgmt-targeted (Mgmt−/−) mice treated with alkylating agents develop HCC [144]. This evidence concerns the gene MGMT and hepatocellular carcinoma.